Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
02/04/2024 01:59
April 2 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* LOSS FOR YEAR ATTRIBUTABLE HK$107.7 MILLION VERSUS PROFIT
HK$4.6
MILLION
* FY REVENUE HK$69.5 MILLION VERSUS HK$41.5 MILLION
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital